The Breast CRG was originally established in 2006 and has been instrumental in developing guidelines and care pathways for the diagnosis and treatment of breast cancer. This has included the development and implementation of the Self-Directed Aftercare pathway which aims to support patients to get back to living their lives following treatment for breast cancer, with remote monitoring replacing routine follow up for identified patients.
For more information on the NICaN Breast CRG please contact nican.office@hscni.net
- Tamoxifen Leaflet For women with a family history of breast cancer deciding whether to take tamoxifen for risk reduction
- Raloxifene Leaflet For women with a family history of breast cancer deciding whether to take raloxifene for risk reduction
- Chemoprevention Patient Info Leaflet for those at an increased risk of familial breast cancer
- Anastrozole Leaflet for post-menopausal women with a high risk of breast cancer